Opinion
YouTube on MSNOpinion

Finding the standard form of a parabola given vertex and focus

Learn how to write the equation of a parabola given the vertex and the focus. A parabola is the shape of the graph of a quadratic equation. A parabola can open up or down (if x is squared) or open ...

From dust to planets: Parabolic flight reveal a turbulent path

How does fine dust aggregate into building blocks that ultimately form entire planets like our Earth? A research team led by ...
YouTube on MSNOpinion

What is vertex form of a parabola EQ

Learn all about parabolas in conic sections. We will discover the basic definitions such as the vertex, focus, directrix, and ...
Yahoo Finance

Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be reporting results this Thursday afternoon. Here’s what you need to know. Vertex Pharmaceuticals met analysts’ revenue expectations last ...
Seeking Alpha

Vertex Q4 Earnings Preview: What To Expect This Week

Vertex Pharmaceuticals is downgraded to Hold ahead of Q4 earnings due to underwhelming growth from key new drugs. Journavx and Casgevy sales remain niche, raising doubts about their ability to drive ...
The Boston Globe

Vertex’s CRISPR treatment for sickle cell disease hits unexpected roadblock

This story is republished from STAT, the health and medicine news site that’s a partner to the Globe. Sign up for STAT’s free Morning Rounds newsletter here. Vertex executives warned that Casgevy, its ...
Yahoo Finance

Vertex Pain Setback Prompts Fund Exit And Recheck Of Valuation Gap

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Vertex Pharmaceuticals (NasdaqGS:VRTX) is reassessing its pain management program ...
Business Wire

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced business and program updates ahead of upcoming investor meetings in January, including the company’s ...
FiercePharma

Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...
STAT

Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Seeking Alpha

Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns

Vertex Pharmaceuticals Incorporated is downgraded from Buy to Hold due to mounting headwinds and pipeline uncertainties. Vertex faces pressure from potential U.S. drug pricing reforms and tariffs, ...
Bloomberg L.P.

Vertex Falls After FDA Doubts Broad Use of Chronic Pain Drug

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...